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C
ancer is the second-leading cause of death in the
U.S.
1 According to U.S. Cancer Statistics,
2 more
than 560,000 people died from cancer in 2007.
Screening reduces cancer mortality, and in some cases,
incidencefrombreast,cervical,andcolorectalcancers.
3–5
The U.S. Preventive Services Task Force recommends
age-appropriate screening for breast cancer with mam-
mography; cervical cancer with Pap tests; and colorectal
cancers with fecal occult blood test (FOBT), flexible sig-
moidoscopy, or colonoscopy.
3–5
Although screening use has improved over time for
several screening tests,
6–8rates are still suboptimal. This
is particularly true for colorectal cancer screening; ap-
proximately 35%–50% of the population has not been
screened at recommended intervals.
8–11 For breast can-
cerscreening,25%–30%ofage-eligiblewomenreportnot
having had recent mammograms
6,11; for cervical cancer
screening, approximately 20% of women aged 18–44
years have not had Pap tests within the prior 3 years.
6,11
Rates of regular screening use are even lower,
12,13 and
screening rates have not risen in recent years.
14 Further,
for many cancers, there are disparities in screening use
for underserved groups, such as those with low income,
no insurance, or no usual source of care.
8,11,14–16 Inter-
ventions to increase appropriate screening use can help
achieve national screening objectives (www.healthy-
people.gov/2020) and save lives, and may reduce dispar-
ities in screening.
TheGuidetoCommunityPreventiveServices(Commu-
nityGuide),undertheguidanceoftheindependent,non-
federal Community Preventive Services Task Force (the
Task Force), previously conducted systematic re-
views
17–20 on effectiveness of interventions to increase
screening for breast, cervical, and colorectal cancers. Ev-
idence for reviews was based on studies published be-
tween 1966 and 2004, and provided the basis for Task
Force recommendations for intervention use. Interven-
tions selected for these reviews were included in one of
three strategies conceptualized to increase screening: in-
creasing community demand for screening, reducing
barriers to access, and increasing screening service deliv-
ery by healthcare providers. The fırst two strategies in-
cluded client-directed approaches; the third strategy in-
cluded provider-directed approaches to promote use of
appropriate screening.
Eleven intervention categories were defıned and
grouped within these three strategies, which are as
follows:
● client reminders, client incentives, one-on-one educa-
tion, group education, mass media, and small media
(increasing community demand);
● reducingclientout-of-pocketcostsandreducingstruc-
tural barriers (enhancing access);
● provider reminders, provider assessment and feed-
back, and provider incentives (increasing provider
delivery).
Findings from these reviews led to Task Force recom-
mendationsforseveninterventionstoincreaseuseofone
or more of these recommended cancer screening tests.
There was insuffıcient evidence to determine the effec-
tiveness for remaining intervention categories.
17–20
Giventhenumberofinterventioncategoriesforwhich
effectiveness was not established for one or more cancer
screening sites, the relative lack of evidence across re-
views for colorectal cancer screening, and the particular
needtoincreaseuptakeofcolorectalcancerscreeningin
appropriate populations, the Community Guide team,
Task Force, and the Cancer Prevention and Control
Research Network (CPCRN) sought to update these
systematic reviews. This article presents results from
the updated reviews of effectiveness for group educa-
tion, one-on-one education, client incentive, client re-
minder, mass media, reducing out-of-pocket costs, re-
ducing structural barriers, provider assessment and
feedback, and provider incentive interventions to in-
crease screening for breast, cervical, and colorectal
cancers. Summary Task Force fındings from the origi-
nal reviews and from these updates are presented in
Table 1.
These updated reviews sought to address three
questions:
● whether interventions for which there was insuffıcient
evidence to determine effectiveness in the previous
reviews
17–20 now had suffıcient evidence to determine
effectiveness;
● whether additional evidence would lead to a change in
fındings for interventions found to have suffıcient or
strong evidence of effectiveness on previous review;
● what important research gaps remain.
An updated review for small media interventions is
underway. A review
17 of provider reminders was pub-
lished recently.
Evidence Acquisition
MethodsforconductingtheoriginalCommunityGuidesystematic
reviews of interventions to increase breast, cervical, and colorectal
cancer screening are described elsewhere.
21 These methods were
followed for the current updates with the exception of adaptations
described in this section.
Analytic frameworks for the three primary strategies assessed
through updated reviews are shown in Figures 1–3. These frame-
works are unchanged from those used in the original reviews with
the exception that they were revised to incorporate healthcare
system factors. Updated reviews used the same primary strategies,
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a for cancer screening interventions
Intervention Original review ﬁndings
b Updated review ﬁndings
INCREASING COMMUNITY DEMAND FOR SCREENING
Group education
Breast cancer screening Insufﬁcient evidence Recommended: sufﬁcient evidence
Cervical cancer screening Insufﬁcient evidence Insufﬁcient evidence
Colorectal cancer screening Insufﬁcient evidence Insufﬁcient evidence
One-on-one education
Breast cancer screening Recommended: strong evidence Recommended: strong evidence
Cervical cancer screening Recommended: strong evidence Recommended: strong evidence
Colorectal cancer screening Insufﬁcient evidence Recommended: sufﬁcient evidence
c
Client reminders
d
Breast cancer screening Recommended: strong evidence Recommended: strong evidence
Cervical cancer screening Recommended: strong evidence Recommended: strong evidence
Colorectal cancer screening Recommended: sufﬁcient evidence
c Recommended: strong evidence
c
Client incentives
Breast cancer screening Insufﬁcient evidence Insufﬁcient evidence
Cervical cancer screening Insufﬁcient evidence Insufﬁcient evidence
Colorectal cancer screening Insufﬁcient evidence Insufﬁcient evidence
Mass media
Breast cancer screening Insufﬁcient evidence Insufﬁcient evidence
Cervical cancer screening Insufﬁcient evidence Insufﬁcient evidence
Colorectal cancer screening Insufﬁcient evidence Insufﬁcient evidence
INCREASING COMMUNITY ACCESS TO SCREENING
Reducing structural barriers
Breast cancer screening Recommended: strong evidence Recommended: strong evidence
Cervical cancer screening Insufﬁcient evidence Insufﬁcient evidence
Colorectal cancer screening Recommended: strong evidence
c Recommended: strong evidence
c
Reducing out-of-pocket costs
Breast cancer screening Recommended: sufﬁcient evidence Recommended: sufﬁcient evidence
Cervical cancer screening Insufﬁcient evidence Insufﬁcient evidence
Colorectal cancer screening Insufﬁcient evidence Insufﬁcient evidence
INCREASING PROVIDER DELIVERY OR PROMOTION OF SCREENING
Provider assessment and feedback Recommended: sufﬁcient evidence
c Recommended: sufﬁcient evidence
c
Provider incentives Insufﬁcient evidence Insufﬁcient evidence
aStrength of evidence based on the number of available studies, the suitability of study design for evaluating effectiveness, the quality of
execution of studies, the consistency of results across studies, and the magnitude of effect.
21,23
bFindings published in Baron et al.
18,19 and Sabatino et al.
20
cInsufﬁcient evidence to determine effectiveness for colorectal cancer screening with tests other than FOBT
dFor client reminders, the original review was limited to studies with greatest design suitability (e.g., RCTs) because of the large number of such
studies identiﬁed. All update studies for client reminder interventions had greatest design suitability except for one. That study was not
included in the assessment of absolute change in screening use for cervical or colorectal cancer, and exclusion of that study did not change
overall conclusions for any of the three cancer screening sites.
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This report includes updates for nine of these reviews.
Reafﬁrmation Updates, Interval Updates, and Full
Updates
Three types of update approaches were possible. The approach
selected by the team depended on strength of evidence in the
original review. Where evidence of effectiveness was strong or
suffıcient (Table 1), the team pursued reaffırmation and interval
updates, respectively. Where evidence was insuffıcient to deter-
mineeffectiveness,fullupdateswereundertaken.Forreaffırmation
updates, evidence from studies identifıed during update was com-
paredwithevidencefromtheoriginalreviewforconsistency.Inthe
interest of effıciency, scoring studies for quality of execution,
wherebytheinternalvalidityofincludedstudieswasassessedusing
a standardized Community Guide process,
21 was not required,
because these interventions previously were determined to have
strong evidence of effectiveness.
For interval updates, evidence from update studies also was
compared with that from the original review. For these updates,
studies were scored for quality of execution.
21 For full updates,
evidence from the update was combined with evidence from the
original review and synthesized using standard Community Guide
methods.
21 In some instances where reaffırmation or interval up-
dates were undertaken, evidence from both reviews was combined
to address specifıc research questions of interest identifıed by the
team.
Updated reviews were based on evidence from literature pub-
lished between January 2004 and October 2008. Although some
studies in the original review were published in 2004, the original
reviewsdidnotincludetheentirecalendaryearof2004.Thus,2004
was included in the search strategy for updated reviews. Studies
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Figure 1. Analytic framework: client-directed interventions to increase community demand for cancer screening services
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Figure 2. Analytic framework: client-directed interventions to increase community access to cancer screening services
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body of evidence for updates.
The team searched fıve computerized databases for potentially
eligible studies (MEDLINE; the Cumulative Index to Nursing and
AlliedHealthdatabase[CINAHL];theChronicDiseasePrevention
database [CDP, Cancer Prevention and Control subfıeld]; Psy-
cINFO; and the Cochrane Library databases). (Search terms are
available at www.thecommunityguide.org/cancer/screening/
provider-oriented/supportingmaterials/SSclient_provider.html.)
Theteamalsoreviewedcitationsreceivedfromteammembersand
reference lists from articles, as appropriate. Conference abstracts
were not included.
The search identifıed 18,906 citations for which titles and ab-
stracts were screened for potential relevance to the interventions
and outcomes of interest. Full-text review was undertaken for 319
of these articles. As in the original reviews, studies had to (1) be a
primary investigation of at least one of the defıned intervention
categories; (2) be conducted in a country with a high-income
economy
21toincreaseapplicabilitytotheU.S.
22;(3)provideinfor-
mation on one or more cancer screening outcomes of interest
(breast, cervical, and/or colorectal cancer screening); and (4) in-
clude a comparison group that either reflected screening use prior
to intervention implementation or a concurrent group unexposed
to the intervention category of interest. A total of 45 studies quali-
fıed for these reviews.
Qualifying studies were abstracted independently by two ab-
stractors using a standardized abstraction form. Following Com-
munityGuidemethods,informationaboutstudydesignsuitability,
qualityofexecution,sample,interventionandcomparisongroups,
outcomes, and effect was abstracted. When necessary, conflicts
wereresolvedbyreviewbyathirdteammember.Designsuitability
categoriesincludedgreatest,moderate,andleastsuitableaccording
to Community Guide rules.
23 Quality of execution is used to assess
biases and limitations in study execution. Quality was categorized
as good, fair, or limited.
23 Studies of limited quality were excluded
from analyses, consistent with Community Guide rules.
Consistentwithpreviousreviews,interventioneffectivenesswas
evaluatedbyexaminingthedifferencebetweenchangeinscreening
use in the intervention group attributable to the intervention and
concurrent change in the comparison group. When this was not
possible, effectiveness was evaluated either by examining the dif-
ference in post-intervention screening use between groups or
change from pre-intervention to post-intervention in the same
group, depending on the data available. Interpretation of fındings
and conclusions followed Community Guide rules, with evidence
about intervention effectiveness categorized as strong evidence of
effectiveness, suffıcient evidence of effectiveness, or insuffıcient
evidence to determine effectiveness, based on number of available
studies, suitability of study design for evaluating effectiveness,
qualityofexecutionofstudies,consistencyofresultsacrossstudies,
and magnitude of effect.
21,23
Conclusions of insuffıcient evidence to determine effectiveness
do not indicate that interventions are ineffective, but rather that
moreinformationisneededtodeterminewhetherornotinterven-
tions are effective. The number of studies required to determine
effectiveness varied depending on the quality of execution and
designsuitabilityofstudiesincluded.
23Informationaboutpopula-
tions and settings for which recommendations are relevant is pro-
videdintheApplicabilitysections.AccordingtoCommunityGuide
rules,
21 where evidence of intervention effectiveness was suffıcient
orstrong,informationabouteffectiveness,applicability,additional
benefıts and potential harms, barriers to implementation, and re-
search gaps was summarized. Where evidence was insuffıcient to
determine effectiveness, remaining questions about effectiveness
were summarized.
For client reminders, the original review was limited to studies
with greatest design suitability (e.g., RCTs), because of the large
number of such studies identifıed. However, the updated reviews
were expanded to include all designs to maximize the potential to
address additional research questions, including examining incre-
mental effects of client reminder interventions when added to
otherinterventions.Allupdatestudieshadgreatestdesignsuitabil-
ity except for one study. This study was not included in the assess-
ment of absolute change in screening use for cervical or colorectal
cancer. Exclusion of this study did not change overall conclusions
for any of the three cancer screening sites.
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Figure 3. Analytic framework: provider-directed interventions to increase screening for breast, cervical, and colorectal
cancers
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studies that reported only screening tests recommended or of-
feredbutnotcompletedwerenotincludedinthedetermination
of intervention effectiveness. These studies could be used to
provide information about applicability, implementation, and
other effects. Also consistent with the original reviews,
17,20
effectiveness of provider-directed interventions was deter-
minedbyconsideringevidenceacrossallthreecancerscreening
sites combined, as long as there were not differences in effec-
tiveness by screening test. Additional information about Com-
munity Guide methods is available at www.thecommunityguide.org/
about/methods.html.
Evidence Synthesis
Increasing Community Demand for
Screening: Group Education
Deﬁnition. Group education conveys information
about indications for, benefıts of, and ways to overcome
barriers to screening with goals of informing, encourag-
ing, and motivating participants to seek recommended
screening. Group education usually is conducted by
health professionals or by trained lay people who use
presentations or other teaching aids in lectures or inter-
active formats; they often incorporate role modeling or
othermethods.Groupeducationcanbegiventoavariety
of groups, in different settings, and by different types of
educators with different backgrounds and styles.
Breast cancer screening promotion (full update). Of
13 qualifying studies of group education interventions to
increase breast cancer screening, ten
24–33 had greatest
designsuitabilitywithgoodtofairqualityofexecution,
andthree
34–36hadleastsuitabledesignswithfairqual-
ity of execution. Twelve studies
24–34,36 examined post-
intervention completion of mammography screening, as
determined by self-report. One study
35 examined
county-level mammography rates. Most studies
24,26–35
used interactive education programs with one or more
sessions intended to improve participants’ screening
awareness, knowledge, and attitudes. Eight studies fo-
cused specifıcally on breast cancer, and four others ad-
dressed multiple cancers. Where specifıed, interventions
were conducted in the U.S. and specifıcally targeted mi-
nority
26–28,32–36 and elderly
25,26,29,31,35 populations. An
additional study
30 targeted self-identifıed gay, lesbian,
andtransgenderedparticipants.Mostprogramswerede-
livered in churches or homes within communities.
Ofthesestudies,12,with13interventionarms(onereport
24
included two study arms), yielded a post-intervention me-
dianabsolutepercentagepointchangeof11.5(interquar-
tileinterval[IQI]5.5,24.0).Resultsfromtheremaining
study
32 could not be expressed as an absolute percentage
point change. It reported AORs of receiving a mammo-
gram at group (0.82, 95% CI0.44, 1.56) and individual
(1.31, 95% CI0.99, 1.74) levels. Group-level analysis
was adjusted for baseline measures and screening behav-
iors. Individual-level analysis was adjusted additionally
forinterventiongroup,levelofacculturation,age,educa-
tion, and insurance status.
Cervical cancer screening promotion (full up-
date). Five studies qualifıed for the combined body of
evidence; one study
37 identifıed during update was ex-
cluded because of limited quality of execution. Three
qualifying studies
26,28,32 had greatest design suitability
and fair quality of execution and two
36,38 had least-
suitable designs and fair quality of execution. Four stud-
ies
26,28,36,38 examined self-reported Pap test use. For one
study,
36 the type of education (interactive or didactic)
could not be determined; the four remaining studies in-
cluded an interactive format. Education sessions were
delivered by lay health workers or peer facilitators in
three studies
28,32,36 and by health professionals in the
others.Wherespecifıed,interventionswereconductedin
the U.S., among African Americans, Latin Americans,
Filipino Americans, and whites, and in populations of
low-tomixed-ormiddle-classSES.Mostprogramswere
delivered in churches or homes in the community.
Data from four studies could be converted to a com-
monmetricandyieldedapost-interventionabsoluteme-
dian percentage point change in screening completed of
10.6 (range of values: 0 to 59.1). The remaining study
32
reported an AOR of receiving a Pap test at group (0.69
[95% CI0.41, 1.19]) and individual (1.12 [95%
CI0.91, 1.37]) levels. ORs were adjusted for factors de-
scribed in Breast Cancer Screening Promotion, above.
Colorectal cancer screening promotion (full up-
date). Two studies
36,39 were included in the combined
body of evidence. One study
39 with three intervention
armshadgreateststudydesignsuitabilityandgoodqual-
ityofexecution.Theother
36hadleast-suitabledesignand
fair quality of execution. Both studies examined post-
intervention changes in colorectal cancer screening by
FOBT as determined by the proportion of returned
FOBTkits.Onestudy
39offeredinteractivegroupsessions
delivered by peer facilitators, and the other
36 offered ses-
sions delivered by promotoras with an in-class format.
For this study, the team was unable to determine if dis-
cussions were delivered in an interactive or didactic for-
mat. Interventions were interactive education programs
delivered in churches or homes in the community. Pop-
ulations included Latinas, African Americans, and white
Americans. The two studies included four intervention
arms and yielded a median absolute percentage point
change of 4.4 (range of values: 13 to 37).
Conclusion. AccordingtoCommunityGuiderulesofevi-
dence,thereisnowsuffıcientevidencethatgroupeducation
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(Table 1). There still is insuffıcient evidence to determine
theeffectivenessofgroupeducationinincreasingscreening
for cervical cancer and colorectal cancer because of small
numbers of studies, methodologic limitations of identifıed
studies, and inconsistent fındings.
Applicability. Basedonpopulationsandsettingsincluded
in these studies, group education interventions to increase
breast cancer screening should be applicable across a range
of settings and populations, provided they are adapted to
targetpopulationsanddeliverycontext.Resultsfromstudies
targeting specialized populations may not be generalizable
to interventions directed at the general population.
Increasing Community Demand for
Screening: One-on-One Education
Deﬁnition. One-on-one education conveys informa-
tion to individuals by telephone or in person about indi-
cations for, benefıts of, and ways to overcome barriers to
screening with the goal of informing, encouraging, and
motivating people to seek recommended screening.
These messages are delivered by healthcare workers or
other health professionals, lay health advisors, or volun-
teers, and are conducted in medical, community, work-
site, or household settings. Interventions can be untai-
lored to address the overall target population or tailored
according to individual assessments to address the recip-
ient’s individual characteristics, beliefs, or perceived bar-
riers to screening. As defıned for thisreview,one-on-one
education may be accompanied by a small media or a
client reminder component.
Breast cancer screening promotion (reafﬁrmation up-
date). The original review
18 found strong evidence of
effectiveness based on a median increase in mammogra-
phy use across 23 studies of 9.2 percentage points
(IQI4.9, 14.4), and ORs from four additional study
arms in the favorable direction. Nine studies
40–48 were
includedintheupdate.Allhadgreatestdesignsuitability.
As in the original review,
18 outcomes were assessed by
self-report
40,41,46,47 or medical record review.
42–45,48 In-
terventions were delivered in the home
40–48or clinic,
44
by medical
40,44 and nonmedical professionals,
41–43,45–48
by telephone,
40,42,44–48 or in person.
41,43,44 Most studies
included tailored components.
40,42–47 Studies were con-
ducted in the U.S. and included urban
40,41,44,45,48 and
rural populations.
42,43 Studies included participants who
were African-American, Hispanic,
40,41,43,45–48 Asian-
American,
46,47 and Native American
43; had low SES
hadincreasedriskforbreastcancer
46,47;andwerenon-
adherent with recent screening.
Results from two studies
46,47 of participants with in-
creasedbreastcancerriskrangedfrom1to18percentage
point increases in mammography use. Of fıve stud-
ies
40,42,43,45,48 of absolute change not specifıc to partici-
pants at increased risk, the median increase for seven
intervention arms was 11.9 percentage points (range of
values: 6.5 to 15.2).
Tocompareeffectsoftailoredinterventionswiththose
not explicitly tailored (referred to as “untailored”), the
team examined evidence from both reviews. Among the
30 studies measuring absolute change, 23 stud-
ies
40,42,43,45–47,49–65 evaluated 30 tailored intervention
arms,anddemonstratedamedianeffectof9.7percentage
points (IQI6.5, 15.2). For the nine studies
48,56,64,66–71
evaluatingnineuntailoredinterventionarms,themedian
effectwas6.3percentagepoints(IQI2.0,11.4).Findings
from the three studies
56,64,72 in the original review pro-
viding intra-study comparisons of tailored versus untai-
lored intervention arms were consistent with the larger
effect seen for tailored interventions. No update studies
providedinformationaboutbothtailoredanduntailored
interventions.
To examine the effect of one-on-one education inter-
ventionsamongunderservedpopulations,theteamiden-
tifıed nine studies
40,43,45,48–50,52,65,70 from both reviews
that described their samples as including predominantly
low-income women, or that reported that 30% of their
sample had income less than $15,000–$20,000. The me-
dian effect across 13 effect estimates from these nine
studieswas10.4percentagepoints(IQI9.4,15.1),com-
pared with a median of 8.8 percentage points (IQI2.0,
14.4) for the remaining 21 studies (n26 effect
estimates).
Theteamalsosoughttoevaluatetheincrementaleffect
of one-on-one education interventions beyond the effect
of other intervention components common to two or
more study arms. Five studies
40,41,44–46 were identifıed
from the update, seven studies
49–51,55,60,63,69 from the
original review, and one study
73 from the review of mul-
ticomponentinterventionsthatallowedthistypeofcom-
parison. Two of these studies
44,63 provided information
aboutthreecomparisonsthatincludedadifferentformof
one-on-one education in comparison groups (e.g., the
incremental effect of phone education beyond the effect
ofin-personeducationcombinedwithotherintervention
components
44). Across all 13 studies (n15 effect esti-
mates), the overall median incremental effect was 6.1
percentage points (IQI2.0, 11.0). Effects for the three
comparisons that included forms of one-on-one educa-
tion in comparison groups were 17.4, 3.0, and 11.0
percentage points.
Cervical cancer screening promotion (reafﬁrmation
update). Theoriginalreview
18foundstrongevidenceof
effectiveness based on a median increase of 8.1 percent-
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fıve tailored intervention arms, and two studies evaluat-
ing three untailored arms. No additional studies were
identifıed during update.
Colorectal cancer screening promotion (full up-
date). All seven qualifying studies in the combined
bodyofevidencehadgreatestdesignsuitability,four
74–77
with good and three
78–80with fair quality of execution.
Most studies
75,76,78,80 ascertained screening use via med-
ical record review, although others reviewed appoint-
ment attendance,
77 screening program records,
79 or as-
certained use by self-report confırmed by physician
survey.
74 Interventions were delivered in both
home
74,77–79 and clinic settings,
75,76,80 by phone,
77–79 in
person,
74–76,80 or by medical professionals
74,75,80 or oth-
ers.
74,76–79 Three studies
74,78,79 evaluated tailored inter-
ventions. Most studies included participants aged 50
years, although two included participants in their
40s.
74,80 In addition to white participants, studies in-
cluded African-American,
75,77 Hispanic,
75 and Asian-
American
74,76 participants; participants with low
SES
76,80; and urban populations.
75–77 No studies speci-
fıed inclusion of rural populations. One study
74 included
participants at increased risk due to a fırst-degree family
historyofcolorectalcancer.Allstudieswereconductedin
the U.S.
These seven studies evaluated 15 intervention arms
(one study
80 included six intervention arms) and re-
ported outcomes for FOBT (n10 effect esti-
mates)
75,76,78–80; flexible sigmoidoscopy (n1 effect es-
timate)
78; colonoscopy (n2 effect estimates)
78,80; and
with any test (n2 effect estimates).
74,78 The median
effect for FOBT was 19.1 percentage points (IQI12.9,
25.1). Effects for any cancer screening test ranged from 1
to11percentagepoints,andforcolonoscopyrangedfrom
0 to 11 percentage points. The one study reporting flexi-
ble sigmoidoscopy outcomes reported no effect.
Among the fıve studies of FOBT screening, two evalu-
ated tailored interventions
78,79 and three studies,
75,76,80
withevaluabledatafromeightinterventionarms,didnot.
Effects for tailored interventions ranged from 1 to 20.7
percentage points. The median for untailored interven-
tions was 20.7 percentage points (IQI13.8, 25.8). No
studies included within-study comparisons of tailored
and untailored interventions. The few studies of tailored
and of untailored arms along with overlapping fındings
by tailored status, makes drawing conclusions for FOBT
based on tailoring diffıcult. The team also stratifıed anal-
ysesbywhetherinterventionsweredeliveredbyphoneor
in person, by medical professionals or others, and
whether small media and/or client reminders were in-
cluded.Nocleardifferencesemerged,althoughthenum-
ber of effect estimates in some strata was small.
Conclusion. According to Community Guide rules of
evidence, there is strong evidence that one-on-one edu-
cation is effective in increasing screening for breast and
cervical cancers, and suffıcient evidence of its effective-
nessinincreasingcolorectalcancerscreeningwithFOBT
(Table 1). However, evidence remains insuffıcient to de-
termine the effectiveness of one-on-one education in in-
creasing colorectal cancer screening with other modali-
ties, because too few studies were identifıed, and results
for those studies were inconsistent (colonoscopy).
Applicability. In the original review, the Task Force
concluded that fındings for breast and cervical cancer
screening should apply both to tailored and untailored
interventions across a range of populations, provided
interventionprogramswereadaptedtotargetpopulation
and delivery context. Studies included in the update sup-
port these conclusions. Recommendations for colorectal
cancer screening with FOBT also should apply across a
range of populations. Although no studies explicitly
noted the inclusion of rural populations, fındings are not
expected to differ substantially from those of urban and
unspecifıed populations.
Increasing Community Demand for
Screening: Client Reminders
Deﬁnition. Client reminders or recalls are textual (let-
ter, postcard, e-mail) or telephone messages advising
people that their screening is due (reminder) or overdue
(recall). Client reminders may be enhanced by one or
more of the following: follow-up printed or telephone
reminders;additionaltextordiscussionwithinformation
about indications for, benefıts of, and ways to overcome
barriers to screening; and assistance in scheduling ap-
pointments. Interventions can be untailored to address
theoveralltargetpopulationortailoredwiththeintentto
reachonespecifıcperson,basedoncharacteristicsunique
to that person, related to the outcome of interest, and
derived from an individual assessment.
Breast cancer screening promotion (reafﬁrmation up-
date). The original review
18 of client reminders found
strong evidence of effectiveness based on a median in-
creaseof14.0percentagepointsinrecentmammography
(19 studies; IQI2.0, 24.0) and three additional studies
demonstrating an increase in repeat mammography. In
the update, six additional studies
81–86 were included. All
hadgreatestdesignsuitabilityexceptforone
83withleast-
suitable design. Exclusion of this study
83 did not change
overall conclusions.
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ingpromotionwereascertainedviaself-report,
86medical
recordreview,
85administrativerecords,
81,82,84orscreen-
ing program attendance.
83 Interventions included both
textual
83–86 and telephone reminders,
81,82 which in-
cluded automated interactive voice response reminders
(AIVR)byphone
81aswellastailoredinterventions
86and
enhanced interventions
82,84–86 (as in the original re-
view,
18 defıned as including follow-up reminders, addi-
tional text, discussion, or appointment scheduling assis-
tance). Studies included reminders delivered by clinical
practicesororganizations,
81,85screeningprogramsorregis-
tries,
82–84orothersources.
86Wherespecifıed,interventions
were conducted in the U.S.
82,84–86 and Norway.
83 Studies
included white,
82,84–86 African-American,
82,86 and His-
panic participants.
86 No studies specifıed inclusion of
other racial or ethnic groups, although several included
groups of unspecifıed race. Others did not report race or
ethnicity. Individuals with low SES
82,84 and urban or
mixedurban/ruralpopulations
82,84,85alsowereincluded.
Several studies did not report this information.
Of four update studies
81,83,84,86 providing information
about absolute change in mammography use, two
81,83
provided information about recent screening only, de-
fıned as completion of the most recent mammogram
within a specifıed interval; one
84 provided information
about repeat mammography only, defıned as examining
two or more consecutive, on-time mammograms; and
one
86 provided information about both. The only phone
intervention among these four studies was the AIVR
study.
81Whenstudiesfrombothreviewswerecombined
to examine differences by recent versus repeat screening
use, the median increase for recent use was 12.3 percent-
agepoints(IQI3.0,18.9;n30effectestimates)andfor
repeat mammography was 6.0 percentage points
(IQI3.0, 19.1; n8 effect estimates).
Findings from the original review also suggested that
unenhanced,printedremindershavesmallereffectsthan
enhanced or telephone reminders (median 3.6 percent-
age points across 12 studies vs 18.5 percentage points
across 13 studies, respectively). This conclusion was sup-
ported by all nine intra-study comparisons. When the
teamincorporatedupdatestudies,
81,83,84,86includingone
study
84withseparatearmsforunenhancedandenhanced
client reminders, fındings reaffırmed that enhanced or
telephone reminders may have a greater effect (15.5 per-
centage points [IQI7.0, 29.0] vs 4.5 percentage points
[IQI1.9, 14.0]).
Theteamalsoexaminedtheincrementaleffectofclient
reminders beyond the effect of other intervention com-
ponentscommontotwoormorestudyarms.Onestudy
85
in the update, six studies
87–92 in the original review, and
two studies
93,94 from the review of multicomponent in-
terventions enabled this type of comparison. Across all
nine studies (n12 effect estimates), the overall median
incremental effect was 5.0 percentage points (IQI1.6,
6.7).
Onestudy
82intheupdateprovidedinformationabout
the effect of a telephone client reminder in increasing
screeningusebyeitherclinicalbreastexamormammog-
raphy. Because of the different outcome, it was not in-
cluded in analyses of absolute change in mammography
use. This study
82 showed an absolute increase in screen-
ing of 8 percentage points.
Cervical cancer screening promotion (reafﬁrmation
update). Theoriginalreview
18foundstrongevidenceof
effectiveness based on a median increase in Pap test use
across 14 intervention arms of 10.2 percentage points
(IQI6.3, 17.9). In the update, six additional qualifying
studies
81,85,95–98 were identifıed. All had greatest design
suitability except for one
95 with least-suitable design.
This study
95 was not included in the assessment of abso-
lute change in screening use; exclusion of this study did
not change overall conclusions.
Outcomesforupdatestudiesofcervicalcancerscreen-
ing promotion were ascertained via medical record re-
view,
85administrativerecords,
81orscreeningregistryre-
cords.
96–98Methodofascertainmentwasnotreportedin
one study.
95 Interventions included printed reminders
only,
85,96,98 telephone reminders only,
81 and printed re-
minders with telephone follow-up reminders.
95,97 Re-
minders were delivered by clinical practices or organiza-
tions
81,85,95 and screening programs or registries.
96–98
No studies included tailored interventions, and
four
85,95,97,98 included enhanced interventions. Where
specifıed, interventions were conducted in the U.S., Swe-
den,
97 Belgium,
96 and Australia.
95,98 One study
85 re-
ported including nonwhite participants but did not pro-
vide more-specifıc information. The remaining studies
did not report race/ethnicity. The one study
97 that re-
ported SES included low-SES participants. Three stud-
ies
85,95,98 included urban or mixed urban/rural popula-
tions.Theotherthreestudies
81,96,97didnotreporturban/
rural status.
Four studies
81,96–98 evaluating fıve intervention arms
provided information about absolute changes in screen-
ing use. One
97 provided information about both fol-
low-up printed reminders and follow-up telephone re-
minders. The median increase was 2.8 percentage points
(rangeofvalues:1.6to31.4).Althoughtheincreaseinthe
update was smaller than in the original review,
18 effect
estimates from the update fell within the range of effects
in the original review.
As for breast cancer screening, fındings from the
original review
18 suggested that unenhanced printed
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telephone reminders (median increase 9.8 percentage
points vs 15.5 percentage points, respectively). This
conclusion was supported by one intra-study compar-
ison.
18 Among three update studies
81,97,98 evaluating
four intervention arms that included telephone and/or
enhanced reminders, the range of effects was 1.6 to
31.4 percentage points. The one update study of
printedunenhancedremindersreporteda1.8percent-
age point increase.
96 No differences were noted ac-
cording to other study characteristics, although there
were few update studies, which limited the authors’
ability to detect differences.
Theteamalsoexaminedtheincrementaleffectofclient
reminders beyond the effect of other intervention com-
ponentscommontotwoormorestudyarms.Onestudy
85
in the update interval, one study
99 in the original review,
and two studies
93,94 from the original review of multi-
component interventions enabled this type of compari-
son. These studies evaluated fıve intervention arms and
provided information about the incremental effect of cli-
ent reminders in addition to provider-directed interven-
tions. The overall median incremental effect was 3.7 per-
centagepoints(rangeofvalues:3.5to25.2).Oneupdate
study
95 reported the relative increase in number of Pap
tests performed over 2 years to be 6.3%. Because of the
different outcome (i.e., number of tests), it was not in-
cluded in analyses of absolute change.
Colorectal cancer screening promotion (interval up-
date for fecal occult blood testing). The original re-
view found suffıcient evidence of effectiveness for client
reminders to increase colorectal cancer screening with
FOBT based on a median increase across four studies
(n8 effect estimates) of 11.5 percentage points
(IQI8.9, 20.3). The update included three additional
studies.
85,100,101 All had greatest design suitability except
for one
101 with least-suitable design. That study was not
included in the assessment of absolute change in screen-
ing and its exclusion did not change overall conclusions.
All three studies had fair quality of execution.
Outcomes for update studies were ascertained via sur-
vey
100 and medical record review.
85,101 All interventions
were printed, none were tailored, and two
85,100 were en-
hanced.Remindersweredeliveredbyclinicalpracticesor
organizations
85,101 or screening programs.
100 Where
specifıed, interventions were conducted in the U.S. and
Italy.
101One
85studyreportedincludingnonwhitepartic-
ipants, although it did not provide more-specifıc infor-
mation. The remaining studies did not report race/eth-
nicity. Two studies
85,100 included mixed urban/rural or
non-urban populations; the third did not report urban/
rural status.
No update studies provided information about abso-
lute changes in screening. The two studies
85,100 with
greatest suitability provided information about incre-
mental effects of client reminders on FOBT screening.
Onestudy
80fromtheoriginalreviewandtwostudies
93,94
from the review of multicomponent interventions also
allowed this type of comparison for FOBT screening.
Across all fıve studies
80,85,93,94,100 evaluating nine inter-
vention arms, the median incremental effect for FOBT
use was 10.9 percentage points (IQI6.0, 13.5).
Nostudiesintheoriginalreviewprovidedinformation
about colorectal cancer screening with tests other than
FOBT. Two update studies
85,100 evaluating fıve interven-
tion arms provided information about incremental ef-
fectsofclientremindersonuseofflexiblesigmoidoscopy,
colonoscopy, or barium enema. The median increase
across these fıve effect estimates was 0.5 percentage
points (range of values: 0.0–6.0). One study
100 reported
the incremental effect on completion of any colorectal
cancer screening test (FOBT, flexible sigmoidoscopy,
colonoscopy, or barium enema) to be 1.0 percentage
point.
One update study
101 provided information about a
printed follow-up reminder to participants randomized
to one of fıve screening-test regimens who did not re-
spond. The outcome was FOBT or flexible sigmoidos-
copy completion. Because of the different nature and
outcome of this study,
101 it was not included in analyses
of absolute or incremental change. Absolute increases
associated with reminders were reported to be 9.2% and
11.1% for participants invited to complete mailed FOBT
kitsandFOBTdeliveredbygeneralpractitioners,respec-
tively, and 3.3% for participants invited to complete one-
time sigmoidoscopy and 3.2% for flexible sigmoidoscopy
followed by FOBT.
Conclusion. According to Community Guide rules of
evidence, there is strong evidence that client reminders
are effective in increasing screening for breast and cervi-
cal cancers and for colorectal cancer with fecal occult
blood testing (Table 1). However, evidence remains in-
suffıcient to determine its effectiveness in increasing
colorectal cancer screening with other tests (colonos-
copy, flexible sigmoidoscopy) because evidence from the
two additional studies identifıed produced inconclusive
results.
Applicability. Theoriginalreview
18concludedthatrec-
ommendations for client reminder interventions to in-
creasescreeningforbreast,cervical,andcolorectalcancer
(FOBT only) should be applicable across a range of set-
tings and populations, provided they are adapted to the
targetpopulationsanddeliverycontext.Studiesincluded
during the update support these conclusions.
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Screening: Client Incentives
Deﬁnition. Client incentives are small, noncoercive re-
wards (e.g., cash or coupons) to motivate people to seek
cancer screening for themselves or to encourage others
(e.g., family members, close friends) to seek screening.
Incentives are distinct from interventions designed to
improve access to services (e.g., transportation, child
care, reducing client out-of-pocket costs).
Breast cancer screening promotion (full up-
date). One study
102 qualifıed for review and had great-
est design suitability and fair quality of execution. This
study evaluated the effect of a $10 incentive for women
whocompletedmammographyscreeningthrougha pre-
existing program that provided free mammograms to
low-income, under-, or uninsured women. The inter-
vention was sent to all women in a commercial data-
base who were aged 40–63 years and from census
blocks having household size and income characteris-
tics consistent with program guidelines. However,
only program-eligible women were included in assess-
ing mammography completion.
Thestudyprovidedinformationabouttheincremental
effect of adding client incentives to screening availability
informationandappointmentschedulingassistance.The
incremental effect was 0.52 percentage points (95%
CI0.32, 0.72). Results restricted to women eligible for
the free screening program, rather than all women in the
identifıed census blocks, yielded an incremental effect of
2.0 percentage points.
Cervical cancer screening promotion (full up-
date). No qualifying studies evaluating the effect of client
incentives on cervical cancer screening were identifıed.
Colorectal cancer screening promotion (full up-
date). No qualifying studies evaluating the effect of client
incentives on colorectal cancer screening were identifıed.
Conclusion. According to Community Guide rules of
evidence, there is insuffıcient evidence to determine the
effectivenessofusingclientincentivestoincreasescreen-
ingforbreast,cervical,orcolorectalcancers,becauseonly
one study
102 for breast cancer and no studies for cervical
and colorectal cancers qualifıed for review (Table 1).
Increasing Community Demand for
Screening: Mass Media
Deﬁnition. Mass media—including TV, radio, newspa-
pers, magazines, and billboards—are used to communicate
educationalandmotivationalinformationincommunityor
larger-scale intervention campaigns. Mass media interven-
tions,however,almostalwaysincludeothercomponentsor
attempt to capitalize on existing interventions and infra-
structure. This review evaluated the effectiveness of mass
mediausedaloneoritsindividualcontributiontotheeffec-
tiveness of multicomponent interventions.
Breast cancer screening promotion (full update). Two
studies
103,104qualifıedforreview.Bothhadfairqualityof
execution,one
103withgreatestandone
104withmoderate
design suitability. One study
104 evaluated the effect of a
radioandnewspaperadvertisementcampaigncompared
withusualcareamongurban,Italian-speakingwomenin
Australia. The outcome was the number of mammo-
gramsperformedpermonth,ascertainedthroughreview
of screening program records. For women in their 50s,
the relative percentage change in number of mammo-
grams completed was 16.1% for initial screens and
4.2% for subsequent screens. Among women in their
60s, the relative percentage changes were 10.8% and
9.0% for initial and subsequent screens, respectively.
The second study
103 compared a multicomponent in-
terventionincludingahigher-intensitymassmediacom-
ponent (messages on city buses, newspaper ads and/or
articles, radio and/or TV programs, and public service
announcements) with a multicomponent intervention
including a lower-intensity mass media component
(campus newspapers and yard signs [reported seldom to
beemployed]).Othercomponentsinbotharmsincluded
group education, small media, and health fairs. The sam-
ple included African-American women living in census
tracts with a high proportion of African-American resi-
dents. The outcome was self-reported completion of a
mammogram within 2 years; clinical breast exam within
2 years also was reported. The absolute change in screen-
ing was 2.4 percentage points (95% CI 9.0, 4.2) for
mammography and 4.2 percentage points (95% CI
1.1, 9.5) for clinical breast exam, respectively. No stud-
ies included information provided through other modes,
such as magazines or the Internet.
Cervical cancer screening promotion (full up-
date). Three studies qualifıed for review, of which
two
103,105 had greatest and one
106 had least-suitable de-
signs.Allhadfairqualityofexecution.Thetwostudiesfrom
the original review included three intervention arms. Rela-
tivepercentageincreasesinPaptestcompletionascertained
by record review were reported to be 20.4% and 47.6% in
onestudyand21.3%intheother.Theupdatestudyassessed
the effect of higher- versus lower-intensity mass media as
part of a multicomponent intervention (described further
above). The absolute change in women screened within
2 years was 4.7 percentage points.
Colorectal cancer screening promotion (full up-
date). One study
103 qualifıed for review. This study ex-
amined the effect of higher- versus lower-intensity mass
Sabatino et al / Am J Prev Med 2012;43(1):97–118 107
July 2012media as part of a multicomponent intervention (de-
scribed further above). Outcomes included ever having
had FOBT and ever having had proctoscopy. (Like
colonoscopy or sigmoidoscopy, proctoscopy involves in-
sertion of a tube into the rectum to look for signs of
cancer or other problems, although proctoscopy is an
older test that used a rigid tube.
107) The absolute change
in screening was 4.7 percentage points (95% CI
12.3, 2.9) for FOBT, and 8.0 percentage points (95%
CI 15.2, 0.8) for proctoscopy.
Conclusion. According to Community Guide rules of
evidence, there is insuffıcient evidence to determine the
effectiveness of mass media interventions in increasing
screening for breast, cervical, and colorectal cancers be-
cause too few studies qualifıed for review (Table 1).
Increasing Community Access to Screening:
Reducing Structural Barriers
Deﬁnition. Structural barriers are non-economic bur-
dens or obstacles that impede access to screening. Inter-
ventions designed to reduce these barriers may facilitate
access by reducing time or distance between service de-
liverysettingsandtargetpopulations;modifyinghoursof
service to meet client needs; offering services in alterna-
tive or nonclinical settings (e.g., mobile mammography
vans at worksites or in residential communities); and
eliminatingorsimplifyingadministrativeproceduresand
otherobstacles(e.g.,schedulingassistanceorpatientnav-
igators, transportation, dependent care, translation ser-
vices,limitingthenumberofclinicvisits).Suchinterven-
tions often include one or more secondary supporting
measures, such as printed or telephone reminders; edu-
cationaboutcancerscreening;informationaboutscreen-
ingavailability(e.g.,groupeducation,pamphlets,orbro-
chures);ormeasurestoreduceclientout-of-pocketcosts.
Interventions principally designed to reduce client costs
are considered a separate class of approaches (discussed
below).
Breast cancer screening promotion (reafﬁrmation up-
date). The original review
19 found strong evidence of
effectiveness for reducing structural barriers to breast
cancer screening, based on a median overall increase in
mammography use across seven studies of 17.7 percent-
age points (IQI11.5, 30.5). The update included one
additional study
108 with a least-suitable study design.
That study examined self-reported, post-intervention
completion of mammography, and clinical breast exam
screening. The intervention was a 1-day community cel-
ebration in Hawaii with personalized recruitment, one-
on-one talk story education sessions, and culturally rele-
vant education brochures. Subjects met with physicians
of the same gender, who were flown in for the event.
Otherhealthissuesalsowerediscussed(e.g.,prostateand
colorectal cancer screening). Women residing on
MolokaiIslandwhowereaged40yearswereeligiblefor
mammography screening. The post-intervention in-
crease in mammography screening was 18 percentage
points (95% CI 1.0, 37.0). The secondary outcome,
clinical breast examinations, increased by 34 percentage
points (95% CI19.0, 49.0).
Cervical cancer screening promotion (full up-
date). Three studies qualifıed for review. Two stud-
ies
109,110wereofgreatestdesignsuitabilitywithfairqual-
ity of execution, and the remaining study
111 had a least-
suitable design with fair quality of execution. All three
studies of reducing structural barriers examined self-
reported, post-intervention Pap test use. Two of three
studies
109–111 investigated effectiveness of alternative
screening sites. One study
111 examined a nurse-led clinic
within a correctional facility, and another
110 offered on-
sitescreeningtoresidentsatahigh-riseapartmentbuild-
ing. The fınal study
109 invited participants to receive
screening during extended hours. Studies were con-
ducted in the U.S., Canada, and Australia. Participants
included low-income female residents of a high-rise
apartment building,
110 incarcerated women,
111 and fe-
male patients of a university-based general practice who
were due or overdue for screening.
109 For the overall
body of evidence, the median increase in Pap screening
was 13.6 percentage points (range of values: 5.9–17.8).
Colorectal cancer screening promotion (reafﬁrmation
update). Theoriginalreview
19foundstrongevidenceof
effectiveness of interventions to reduce structural barri-
ers to colorectal cancer screening with FOBT. The me-
dianincreasewas16.1percentagepoints(IQI12.1,22.9;
n11 effect estimates). Five additional studies were in-
cluded in the update. Four studies
108,112–114 had least-
suitable study designs and fair quality of execution. One
study
115 had greatest suitability of study design, with
good quality of execution.
Outcomes in update studies included completion of
FOBTalone
112,115;colonoscopyorFOBT(includingfecal
immunochemical tests)
113; any of the three testing mo-
dalities (FOBT, sigmoidoscopy, or colonoscopy)
108; and
the mean number of colonoscopies per month.
114 Out-
comes were ascertained by proportion of returned
kits,
112,115self-report,
113andmedicalrecord
108orhospi-
tal record review.
114 Most evidence focused on ap-
proaches to reduce time and distance to completing
screening (e.g., mailing FOBT cards to clients). Studies
were conducted in the U.S. and France and in medical
care and community settings. All studies enrolled men
and women aged 50 years. One study
112 enrolled par-
ticipantswhoweredueoroverdueforscreening.Another
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115 enrolled participants who had not received
screeninginthepreviousyear.Theremainingstudiesdid
not specify screening histories. Specifıed racial/ethnic
groups included whites, Hispanics/Latinos, African
Americans, and Native Hawaiians. Included populations
also varied, from residents of urban communities
113 to
residents of a remote Hawaiian Island.
108
Based on four effect estimates in the update studies,
there was a median 36.9 percentage point increase across
colorectal cancer screening tests (range of values: 16.3 to
41.1). Additional evidence showed a 9.5% relative in-
crease in the mean number of colonoscopies per
month.
114
Conclusion. According to Community Guide rules of
evidence, there is strong evidence that reducing struc-
tural barriers is effective in increasing screening for
breast and colorectal cancers (by mammography and
FOBT, respectively; Table 1). Evidence is insuffıcient,
however, to determine whether reducing structural
barriers is effective in increasing colorectal cancer
screening by flexible sigmoidoscopy or colonoscopy
becauseonlyonestudy
114usingthesescreeningproce-
dures was identifıed. Evidence was also insuffıcient to
determine the effectiveness of reducing structural bar-
riers in increasing screening for cervical cancer be-
cause only three relevant studies were identifıed, and
these had methodologic limitations.
Applicability. The original review concluded that the
evidenceforreducingstructuralbarriersinterventionsto
increase breast cancer screening should be applicable
across a range of settings for target populations with
limited access to mammography. That review placed
heavyemphasisonstrategiestoreducetimeanddistance
or create alternative screening locations. In addition to
including populations similar to the original review, the
updated body of evidence included a study that focused
on rural populations. Hence, fındings from the original
reviewaresupported,suchthatrecommendationsshould
applyacrossarangeofpopulationsandsettings,provided
that programs are adapted to target populations and de-
livery contexts.
For colorectal cancer screening, original review fınd-
ings were limited to FOBT screening and applicable
across a range of settings where target populations may
have limited physical access to FOBT. Included studies
generally represented white and African-American pop-
ulations but no other racial ethnic groups. For the up-
dated review, applicability may be expanded, given the
addition of studies from another high-income econ-
omy
112 and studies whose samples included other popu-
lations (e.g., Native Hawaiians, Hispanics).
Increasing Community Access to Screening:
Reducing Out-of-Pocket Costs
Deﬁnition. These interventions attempt to minimize or
remove economic barriers that impede client access to
cancerscreeningservices.Costscanbereducedthrougha
variety of approaches, including vouchers, reimburse-
ments, reduction in copays, or adjustments in federal or
state insurance coverage. Efforts to reduce client costs
maybecombinedwithmeasurestoprovideclienteduca-
tion, information about program availability, or mea-
sures to reduce structural barriers.
Breast cancer screening promotion (interval up-
date). The original review
19 found suffıcient evidence
of effectiveness to recommend interventions that reduce
out-of-pocket costs to promote breast cancer screening,
basedonamedianincreaseincompletedmammography
across eight intervention arms of 11.5 percentage points
(IQI6.0, 28.5). No additional studies were identifıed
during the update.
Cervical cancer screening promotion (full up-
date). One study
116 qualifıed for review and had least-
suitable design and fair quality of execution. This study
reported an increase in completed Paps tests of 17 per-
centage points.
Colorectal cancer screening promotion (full up-
date). No qualifying studies of reducing client out-of-
pocket costs interventions to increase colorectal cancer
screening were identifıed.
Conclusion. According to Community Guide rules of
evidence, there is suffıcient evidence that reducing client
out-of-pocketcostsiseffectiveinincreasingscreeningfor
breast cancer (Table 1). There is insuffıcient evidence to
determine its effectiveness in increasing screening for
cervical or colorectal cancer because too few (cervical
cancer) or no (colorectal cancer) studies were identifıed.
Nonetheless, the consistently favorable results for inter-
ventionsthatreducecostsforbreastcancerscreeningand
several other preventive services suggest that such inter-
ventions are likely to be effective for increasing cervical
and colorectal cancer screening as well.
Applicability. Theoriginalreview
19concludedthatrec-
ommendations for use of interventions that reduce out-
of-pocket costs to increase screening for breast cancer
should be applicable across a range of settings and popu-
lations where target populations may have limited fınan-
cial resources for mammography. Because no additional
studies were identifıed during the update, conclusions
about applicability remain unchanged.
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Screening: Provider Assessment and
Feedback
Deﬁnition. Providerassessmentandfeedbackinterven-
tions both evaluate provider performance in offering
and/or delivering screening to clients (assessment) and
present providers with information about their perfor-
mance in providing screening services (feedback). Feed-
backmaydescribetheperformanceofagroupofprovid-
ers (e.g., mean performance for a practice) or individual
providers and may be compared with a goal or standard.
Breast, cervical, and colorectal cancer screening pro-
motion (full update). Nine qualifying studies
117–125
were included in the review. Four studies
117,122–124 had
greatest,two
119,125hadmoderate,andthree
118,120,121had
leastsuitabledesigns.Qualityofexecutionwasfairforall
except two,
121,122 for which it was good.
Seven studies
118,120–125 reported completed screening,
and four studies
117,119,121,123 reported screening ordered by
providers.Nostudiesoforderedscreeningwereincludedin
the update. Completed screening outcomes were ascer-
tainedthroughmedicalrecordreview.
118,120–123,125Assess-
ment of provider screening performance was conducted
byprovidersauditingchartsoftheirownpatients
118or
another provider’s patients,
120 via computer
search
123,124 or chart review by researchers
121,122 or
others.
125 Feedback was provided concerning individ-
ual provider performance,
120,124 group perfor-
mance,
121,125 or both.
118,122,123 Feedback received by
providers varied from a single occurrence
118,121 to regu-
lar intervals.
120,122–125 Studies of completed screening
were conducted in the U.S.
120–125 and the United King-
dom,
118 and included both trainee
120,122–124 and non-
trainee physicians.
118,121 Two studies specifıed patient
race/ethnicity, including African-American, Hispanic,
and Asian participants,
122,123 and several specifıed the
inclusion of urban
120,122,124 and rural groups.
121
For completed screening, four effect estimates
121–124
were included for mammography, four
118,120,122,124 for
Pap test, and three
120,122,124 for colorectal cancer screen-
ing with FOBT, with one study
122 also providing an esti-
mate for flexible sigmoidoscopy. One study
125 evaluated
change in use of FOBT, flexible sigmoidoscopy, or
colonoscopy. Findings across all screening sites led to a
median increase in screening use of 13.0 percentage
points (IQI5.5, 21.8). Findings for mammography var-
iedfrom3.4to20.6percentagepoints,forPapfrom4.0to
29.5 percentage points, and for FOBT screening from
12.3 to 23.0 percentage points. The one estimate for flex-
ible sigmoidoscopy showed essentially no effect. The es-
timate from the update study examining FOBT, flexible
sigmoidoscopy, or colonoscopy was a 45 percentage
point increase.
Conclusion. According to Community Guide rules of
evidence,thereissuffıcientevidencethatproviderassess-
ment and feedback interventions are effective in increas-
ingscreeningforbreastcancer(mammography);cervical
cancer (Pap test); and colorectal cancer (FOBT; Table 1).
Evidence was insuffıcient, however, to determine effec-
tiveness of this intervention in increasing colorectal can-
cer screening using methods other than FOBT.
Applicability. The original review concluded that rec-
ommendations to increase screening for breast, cervical,
and colorectal cancer (FOBT only) should be applicable
acrosssettingsandpopulationsdescribed,withthecaveat
that provider training status potentially was related to
magnitude of effect. Considering additional information
from the update, conclusions about applicability remain
unchanged.
Increasing Provider Delivery or Promotion of
Screening: Provider Incentives
Deﬁnition. Provider incentives are direct or indirect
rewards intended to motivate providers to perform
cancerscreeningormakeappropriatereferralfortheir
patients to receive these services. Rewards are often
monetarybutcanincludenonmonetaryincentivesalso
(e.g., continuing medical education credit). Because
some form of assessment is needed to determine
whether providers receive rewards, an assessment
component may be included in the intervention.
Breast, cervical, and colorectal cancer screening pro-
motion (full update). Five studies qualifıed for review.
Of these, three
126–128 had greatest and two
129,130 had
least-suitable designs. All had fair quality of execution
except for one
128 with good quality of execution.
Of these fıve studies, three
128–130 reported completed
screening, one
127 reported recommended or offered
screening, and one
126 reported both. The four studies of
completedscreeningascertainedoutcomesfrommedical
records,
126,129 self-report,
126 performance reports,
128 or
claims data
130 from health plans. Interventions included
provider incentives alone
128–130 or with provider assess-
ment and feedback and reminders.
126
The nature of and details provided about incentives
varied across studies. Interventions included a quarterly
practice bonus of approximately $0.23 per member per
month for each performance target met, with bonus po-
tential representing approximately 5% of capitation
128;
quarterly practice bonuses with the amount related to
whether higher or lower screening thresholds were
met
129; a physician bonus based on the percentage re-
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a 50% referral rate)
126; and a year-end physician bonus
program with specifıcs of the bonus unavailable.
130
Studies of completed screening took place in the
U.S.
126,128,130 and Scotland.
129 Physician settings ranged
from large, multispecialty organizations
128 to individual
practice associations or physician practices.
126,129,130 Pa-
tient populations included commercially insured health
planmembers
130andpatientsofselectedpractices.
126,129
The four studies of completed screening evaluated
seveninterventionarms:twoformammography,twofor
Pap tests, one for FOBT, one for endoscopic screening,
and one for double-contrast barium enema. The median
changeinscreeninguseacrossstudieswas1.7percentage
points (IQI 0.1, 3.6). Findings for mammography
varied from 2.0 to 1.7 percentage points, for Pap from
3.6 to 8.0 percentage points, and for colorectal screening
from 0.1 to 2.8 percentage points.
Conclusion. According to Community Guide rules of
evidence, there is insuffıcient evidence to determine the
effectiveness of provider incentives in increasing screen-
ing for breast, cervical, or colorectal cancers (Table 1).
Evidence is insuffıcient because results were inconsistent
and generally small.
Additional Beneﬁts and Potential Harms of
Interventions
No reports of other positive or negative effects of inter-
ventions on use of other healthcare services, health be-
haviors, or informed decision making were found while
updatingreviewsinallinterventioncategories.Forclient
incentives, no other positive or negative effects of incen-
tives with small monetary value were identifıed in the
literature reviewed or by the review team. However, the
team noted that, at some point, as the monetary value of
incentives increases, they have the potential to become
coercive.
Potential Barriers to Implementing
Interventions
Ingeneral,limitedresourcesandinfrastructureappearto
be the most important barriers to implementing inter-
ventions.
18 For one-on-one education interventions, re-
cruitment and training of educators, quality-control
measures, duration of educational sessions, travel for in-
person education, and professional backgrounds of edu-
cators may influence costs and feasibility of implementa-
tion.Inadditiontocosts,theseinterventionsmayrequire
special skills or tools to develop messages, including tai-
lored messages, which also may pose implementation
barriers.
18
For client reminders, barriers may include limited in-
frastructure and staffıng and/or computer support to
identify patients due for screening and deliver reminders
effıciently.
18 Further, costs of generating and delivering
reminders may be a substantial barrier, and barriers re-
lated to tailoring may apply.
18 (When done on a large
scale, such interventions may cost little per person.) As
noted in the original review,
19 potential barriers for re-
ducingstructuralbarriersinterventionsmayincludelim-
itedresourcestoprovidemobilemammographyservices,
diffıculty identifying alternative screening sites, ade-
quately staffıng facilities at alternative sites or during
alternative hours, and ensuring follow-up of abnormal
tests for clients lacking access to care. Barriers to imple-
mentation were not addressed for client incentives, mass
media,andproviderincentives,becauseeffectivenesswas
not established for any cancer screening site.
Research Gaps
The team found suffıcient to strong evidence that inter-
ventions using one-on-one education, client reminders,
provider assessment and feedback, and reducing struc-
turalbarriersareeffectiveinpromotingcolorectalcancer
screening with FOBT. However, more information is
needed to determine whether interventions are effective
for other forms of colorectal cancer screening. Effective-
ness for these other tests has not been established for any
intervention.
Further, as new screening tests emerge (e.g., fecal im-
munochemical tests), information will be needed about
whether effects differ for these tests. It is also unknown
whether interventions to promote colorectal cancer
screening are equally effective when specifıc to one type
of test, or when addressing colorectal cancer screening
more generally. Because there is more than one recom-
mended screening test for colorectal cancer, focusing in-
terventions on only one test may limit client choices,
disregard client preferences, or fail to consider provider
preferences.Moreinformationalsoisneededabouteffec-
tiveness of interventions using incentives, both client-
and provider-directed, and mass media. Where informa-
tionabouttheseinterventionsmaybeavailable,orwhere
plans to employ such interventions may already be in
place,thepublicationofsuchdataorevaluationtoexam-
ineeffectivenessoftheseinterventionswouldhelpbridge
these gaps.
Effectiveness of group education and reducing out-of-
pocket cost interventions was established for breast can-
cer screening although not for cervical or colorectal can-
cer screening. However, given consistently favorable
results for interventions that reduce costs for breast can-
cerscreening and other preventive services, there is no
reason to conclude a priori that results for breast can-
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cervical cancer screening. It is not clear whether such
interventions would differentially affect uptake of par-
ticular colorectal cancer screening tests. Client out-of-
pocketcostsvaryamongrecommendedcolorectalcancer
screening tests, with greater costs for colonoscopy than
FOBT.
131,132 Differences in client costs may influence
patient preferences for screening tests.
132
Formanyinterventions,whetherthereisanincremen-
taleffectofaddingtheinterventiontootherinterventions
is unknown. As multicomponent interventions are com-
mon, information about the magnitude of incremental
effectsofaddingspecifıcinterventionstoothersisimpor-
tant to maximize intervention impacts. In spite of this
fact, there is little information about the incremental
effect of specifıc interventions. This review provides in-
formation about the incremental effects of one-on-one
education and client reminder interventions for several
types of cancer screening tests.
Additional questions for ongoing or future studies in-
cludedeterminingwhat,ifany,influencenewermethods
of communication, such as the Internet, e-mail, AIVR,
social media, or texting may have on intervention effec-
tiveness. As these modes of communication become
more prevalent, interventions may be adapted to incor-
porate them. However, it is unknown how this will influ-
ence intervention effectiveness. Additional research
questions are provided in Table 2.
Discussion
These reviews update the evidence base underlying Task
Force recommendations for nine interventions to in-
crease community demand, enhance community access,
and increase provider delivery of recommended cancer
screening services. Recommendations were expanded to
include interventions using one-on-one education to in-
crease colorectal cancer screening with FOBT and group
educationtoincreasemammographyscreening.Further,
the Task Force upgraded the strength of evidence for
client reminder interventions to increase colorectal can-
cer screening with FOBT from suffıcient to strong.
Previous fındings and recommendations were reaf-
fırmedorunchangedforreducingout-of-pocketcostsfor
breast cancer screening; provider assessment and feed-
back for breast, cervical, and FOBT screening; one-on-
one education for breast and cervical cancer screening;
reducing structural barriers for breast cancer and FOBT
screening; and client reminders for breast and cervical
cancer screening. Evidence still is insuffıcient to deter-
mine effectiveness for the remaining screening tests and
intervention categories, largely because of an inadequate
number of qualifying studies. As in the original reviews,
among recommended interventions, the largest effects
were seen for interventions that reduce structural barri-
ers.AsimilarlylargeeffectwasnotedforFOBTscreening
after one-on-one education interventions. To some ex-
tent, effect sizes for different types of interventions to
influence uptake of particular types of cancer screening
(e.g.,mammographyversuscolonoscopy)mayreflectthe
state of diffusion of different kinds of cancer screening
and what is needed to effect change.
The team did not fınd evidence from other recent
reviewsabouttheroleofgroupeducationinbreastcancer
screening. However, the fınding of insuffıcient evidence
todetermineeffectivenessforcolorectalcancerscreening
isconsistentwithotherfındings.
9,133Thenewfındingfor
one-on-one education and the recommendation for cli-
ent reminders to increase colorectal cancer screening
with FOBT are consistent with fındings from a recent
systematicreview
133andAgencyforHealthcareResearch
and Quality Report.
9
Reaffırmed or standing recommendations are supported
by earlier reviews also. Increased cervical cancer screening
was associated with educational interventions,
134 including
“interactive delivery of cognitive educational interventions
by telephone.”
135 Reducing structural barriers was effective
in promoting mammography
136 and increased FOBT
screening.
9,133 Addressing fınancial and logistic concerns
increasedmammographyuseindiversepopulations,
137and
mailed educational materials and telephone reminders
were effective in increasing attendance at community
breast cancer screening activities.
138 Telephone re-
minders also have been found to increase cervical can-
cer screening.
135 For provider-directed interventions,
audit and feedback have been associated with in-
creased mammography screening.
137
In contrast to Task Force fındings, a meta-analysis of
single and multicomponent interventions in minority
women reported that access-enhancing interventions
and group education yielded the greatest benefıts in in-
creasing cervical cancer screening.
139 This may be due to
the particular needs of minority women who also were
economically disadvantaged. Further, home visits were
ineffective in increasing invited attendance at commu-
nity breast cancer activities.
138 Differences among re-
views are likely due in part to differing study inclusion
criteria and classifıcation of interventions, as well as in-
clusion of studies with varied designs and execution,
which makes comparisons of fındings diffıcult.
Updating recommendations for interventions to pro-
mote colorectal cancer screening was a priority for these
reviews. Findings have expanded the list of effective in-
tervention categories to include one-on-one education
(FOBT),andupgradedthestrengthofevidenceforclient
reminders to increase FOBT screening from suffıcient
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tural barriers, to increase FOBT screening, was
reaffırmed.
This is important, given evidence that the factor most
negatively associated with colorectal cancer screening is
lackofhealthcareaccess.
133However,formanyinterven-
Table 2. Research questions for future studies
Overall
Are interventions effective for promoting colorectal cancer screening with methods other than FOBT?
Are interventions to promote colorectal cancer screening equally effective when addressing colorectal cancer screening more
generally, as when speciﬁc to one type of test?
What are the incremental effects of adding intervention components to other interventions?
What inﬂuence do newer methods of communication (e.g., the Internet, e-mail, social media, AIVR, texting) have on
intervention effectiveness?
What is the inﬂuence of health system factors on intervention effectiveness?
Group education
Are group education interventions that target speciﬁc groups more effective in increasing breast, cervical, or colorectal cancer
screening within those groups than untargeted interventions?
Does effectiveness vary with intensity of education sessions or speciﬁc components included in them?
One-on-one education
What duration, dose, and intensity of one-on-one educational interventions are needed to be effective?
18
What characteristics of “tailoring” contribute to its effect? Are there effects of tailoring channels (personal interaction,
anonymous interaction)?
Does effectiveness of one-on-one education interventions vary according to whether or not education is delivered by a
medical professional?
Client reminders
How do newer methods of communication (e.g., the Internet, e-mail, text messages, or automated telephone calls) inﬂuence
the effectiveness of client reminder interventions?
To what extent does effectiveness vary for groups overdue for screening or never screened?
Does effectiveness vary according to the source of client reminders (e.g., clinic or practice versus screening registry or program)?
Do reminders for screenings for multiple cancer sites work as well as those for a single cancer site?
Client incentives
As in the original review,
18 does effectiveness vary with type of incentive?
Is screening use sustained after discontinuation of incentives? Is length of effect related to size or perceived value of
incentives? Is there a value ﬂoor or ceiling?
Is there a threshold beyond which client incentives are effective? If so, is the magnitude of the incentive ethical or coercive?
Are there speciﬁc populations for whom client incentives are valuable? A clearer understanding of the nature of attractive
incentives for different populations would be helpful. Are one-size-ﬁts-all incentives no longer appropriate?
Mass media
What is the efﬁcacy of Internet-delivered mass media campaigns and other mass approaches? Can the Internet be marshaled
to create the impact of mass media at lower cost and with even greater reach?
Provider incentives
Does effectiveness vary with type of incentive, timing of incentive, and/or physician/practice characteristics?
Do provider incentives result in an incremental increase in the effectiveness of provider assessment and feedback
interventions?
20
Note: For interventions with established effectiveness, research issues concerning effectiveness, applicability, additional beneﬁts and
potential harms, and potential barriers to implementation were summarized. For interventions with established effectiveness for one or more
screening sites, unaddressed questions were considered more broadly.
FOBT, fecal occult blood test
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to determine effectiveness for colorectal cancer screen-
ing, most often because of too few qualifying studies.
Given that access to care alone does not ensure adequate
screening use,
133 more information is needed to deter-
mine which of these interventions are effective. More-
over, most evidence is for FOBT use rather than colono-
scopy, which increasingly has been utilized for screening
while FOBT use has declined.
9 Although information
about colorectal cancer screening is increasing, addi-
tional information about endoscopic screening is needed
for many interventions.
In selecting effective interventions to implement, local
needs, barriers, populations, and resources should be
considered,alongwithevidencedataregardingeffective-
ness of different interventions. Targeted, tailored, and
more intensive efforts may be more appropriate when
population subgroups underutilize screening.
135,137 Dis-
parities in colorectal cancer screening and other
screening tests have been described.
8,11,14 In the cur-
rent reviews, for many interventions including ones
recommended for colorectal screening, there were of-
ten too few studies to identify particular intervention
categories or approaches within categories that were
effective for particular subgroups. An exception was
thatforbreastcancerscreening,one-on-oneeducation
appeared similarly effective in studies with relatively
large underserved populations compared with other
studies. More information about various approaches
would help identify which strategies may be most ap-
propriate for given populations and settings.
As with many reviews,
133–135,139 publication bias and
selective reporting of signifıcant results may have influ-
enced fındings. It is also possible that not all relevant
studies were identifıed
133; however, the search strategy
employed was comprehensive, with studies included and
fındings reviewed by a Coordination team of Task Force
members, systematic review methodologists, and subject
matter experts.
140 Additionally, biases within studies may
influence fındings.
134,139 Where applicable, following
Community Guide rules,
23 study quality was assessed in-
dependently by two reviewers using a scoring protocol
developed by the team, including systematic review
methodologists. The strength of the overall body of evi-
dence also was accounted for according to Community
Guide rules.
21,23 Conclusions of insuffıcient evidence to
determineeffectivenessdonotindicatethatinterventions
are ineffective. Instead such fındings imply that addi-
tional research and information are needed before con-
clusionscanbedrawn.Finally,thesereviewsarebasedon
studies published through 2008; more-recent fındings
therefore are not included.
Determining effectiveness of interventions is an im-
portant step to improve screening use among eligible
populations. However, once effective interventions have
been identifıed, dissemination and uptake of these inter-
ventions in community and healthcare settings are criti-
cal to maximizing their utility. Proactive, deliberate ef-
forts are needed to disseminate fındings into practice.
Web-based resources such as Cancer Control PLANET
(cancercontrolplanet.cancer.gov/) can facilitate access to
research-tested cancer control interventions. More re-
search is needed into contextual effects on screening in-
tervention implementation and the process of screening
promotion dissemination.
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